Annual EBIT:
$172.54M+$13.47M(+8.47%)Summary
- As of today, COLL annual earnings before interest & taxes is $172.54 million, with the most recent change of +$13.47 million (+8.47%) on December 31, 2024.
- During the last 3 years, COLL annual EBIT has risen by +$154.90 million (+878.13%).
- COLL annual EBIT is now at all-time high.
Performance
COLL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$37.49M+$13.58M(+56.77%)Summary
- As of today, COLL quarterly earnings before interest & taxes is $37.49 million, with the most recent change of +$13.58 million (+56.77%) on June 1, 2025.
- Over the past year, COLL quarterly EBIT has dropped by -$7.20 million (-16.10%).
- COLL quarterly EBIT is now -43.19% below its all-time high of $65.99 million, reached on December 31, 2023.
Performance
COLL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$135.30M-$7.20M(-5.05%)Summary
- As of today, COLL TTM earnings before interest & taxes is $135.30 million, with the most recent change of -$7.20 million (-5.05%) on June 1, 2025.
- Over the past year, COLL TTM EBIT has dropped by -$78.89 million (-36.83%).
- COLL TTM EBIT is now -36.83% below its all-time high of $214.19 million, reached on June 30, 2024.
Performance
COLL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
COLL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +8.5% | -16.1% | -36.8% |
| 3Y3 Years | +878.1% | +237.3% | +817.3% |
| 5Y5 Years | +891.0% | +126.3% | +242.7% |
COLL EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +878.1% | -43.2% | +868.7% | -36.8% | +1179.2% |
| 5Y | 5-Year | at high | +891.0% | -43.2% | +209.9% | -36.8% | +817.3% |
| All-Time | All-Time | at high | +283.4% | -43.2% | +209.9% | -36.8% | +233.2% |
COLL EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $37.49M(+56.8%) | $135.30M(-5.1%) |
| Mar 2025 | - | $23.91M(-40.1%) | $142.49M(-17.4%) |
| Dec 2024 | $172.54M(+8.5%) | $39.92M(+17.5%) | $172.54M(-13.1%) |
| Sep 2024 | - | $33.97M(-24.0%) | $198.61M(-7.3%) |
| Jun 2024 | - | $44.68M(-17.2%) | $214.19M(+2.4%) |
| Mar 2024 | - | $53.96M(-18.2%) | $209.16M(+31.5%) |
| Dec 2023 | $159.07M(+362.9%) | $65.99M(+33.2%) | $159.07M(+50.3%) |
| Sep 2023 | - | $49.55M(+24.9%) | $105.86M(+37.9%) |
| Jun 2023 | - | $39.66M(+924.8%) | $76.79M(+59.2%) |
| Mar 2023 | - | $3.87M(-69.7%) | $48.25M(+40.4%) |
| Dec 2022 | $34.37M(+94.8%) | $12.78M(-37.6%) | $34.37M(+374.1%) |
| Sep 2022 | - | $20.48M(+84.2%) | -$12.54M(+33.5%) |
| Jun 2022 | - | $11.12M(+211.0%) | -$18.86M(-39.0%) |
| Mar 2022 | - | -$10.01M(+70.7%) | -$13.57M(-176.9%) |
| Dec 2021 | $17.64M(-68.8%) | -$34.12M(-341.1%) | $17.64M(-73.6%) |
| Sep 2021 | - | $14.15M(-13.8%) | $66.76M(-7.6%) |
| Jun 2021 | - | $16.41M(-22.6%) | $72.23M(-0.2%) |
| Mar 2021 | - | $21.20M(+41.3%) | $72.39M(+28.2%) |
| Dec 2020 | $56.46M(+358.9%) | $15.00M(-23.6%) | $56.46M(+43.0%) |
| Sep 2020 | - | $19.63M(+18.5%) | $39.48M(+182.7%) |
| Jun 2020 | - | $16.56M(+214.1%) | $13.96M(+297.4%) |
| Mar 2020 | - | $5.27M(+365.0%) | -$7.07M(+67.6%) |
| Dec 2019 | -$21.81M | -$1.99M(+66.2%) | -$21.81M(-161.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$5.88M(-31.4%) | -$8.33M(+36.3%) |
| Jun 2019 | - | -$4.48M(+52.7%) | -$13.09M(+15.6%) |
| Mar 2019 | - | -$9.47M(-182.4%) | -$15.51M(+18.3%) |
| Dec 2018 | -$19.00M(+74.6%) | $11.49M(+208.0%) | -$19.00M(+60.3%) |
| Sep 2018 | - | -$10.63M(-54.1%) | -$47.89M(+5.2%) |
| Jun 2018 | - | -$6.90M(+46.7%) | -$50.52M(+22.0%) |
| Mar 2018 | - | -$12.95M(+25.6%) | -$64.74M(+13.5%) |
| Dec 2017 | -$74.86M(+20.4%) | -$17.40M(-31.2%) | -$74.86M(+12.0%) |
| Sep 2017 | - | -$13.26M(+37.2%) | -$85.04M(+13.4%) |
| Jun 2017 | - | -$21.12M(+8.5%) | -$98.22M(+3.3%) |
| Mar 2017 | - | -$23.08M(+16.3%) | -$101.57M(-8.0%) |
| Dec 2016 | -$94.08M(-249.7%) | -$27.58M(-4.3%) | -$94.08M(-23.7%) |
| Sep 2016 | - | -$26.44M(-8.0%) | -$76.03M(-29.2%) |
| Jun 2016 | - | -$24.47M(-57.0%) | -$58.85M(-51.1%) |
| Mar 2016 | - | -$15.59M(-63.6%) | -$38.95M(-44.8%) |
| Dec 2015 | -$26.91M(-52.3%) | -$9.53M(-2.8%) | -$26.91M(-29.9%) |
| Sep 2015 | - | -$9.27M(-102.5%) | -$20.71M(-15.4%) |
| Jun 2015 | - | -$4.58M(-29.3%) | -$17.95M(-2.8%) |
| Mar 2015 | - | -$3.54M(-6.4%) | -$17.46M(+1.2%) |
| Dec 2014 | -$17.66M(-9.6%) | -$3.33M(+48.9%) | -$17.66M(-23.2%) |
| Sep 2014 | - | -$6.50M(-59.1%) | -$14.34M(-83.1%) |
| Jun 2014 | - | -$4.09M(-9.2%) | -$7.83M(-109.2%) |
| Mar 2014 | - | -$3.74M | -$3.74M |
| Dec 2013 | -$16.12M | - | - |
FAQ
- What is Collegium Pharmaceutical, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. annual EBIT year-on-year change?
- What is Collegium Pharmaceutical, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. quarterly EBIT year-on-year change?
- What is Collegium Pharmaceutical, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Collegium Pharmaceutical, Inc.?
- What is Collegium Pharmaceutical, Inc. TTM EBIT year-on-year change?
What is Collegium Pharmaceutical, Inc. annual earnings before interest & taxes?
The current annual EBIT of COLL is $172.54M
What is the all-time high annual EBIT for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high annual earnings before interest & taxes is $172.54M
What is Collegium Pharmaceutical, Inc. annual EBIT year-on-year change?
Over the past year, COLL annual earnings before interest & taxes has changed by +$13.47M (+8.47%)
What is Collegium Pharmaceutical, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of COLL is $37.49M
What is the all-time high quarterly EBIT for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high quarterly earnings before interest & taxes is $65.99M
What is Collegium Pharmaceutical, Inc. quarterly EBIT year-on-year change?
Over the past year, COLL quarterly earnings before interest & taxes has changed by -$7.20M (-16.10%)
What is Collegium Pharmaceutical, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of COLL is $135.30M
What is the all-time high TTM EBIT for Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. all-time high TTM earnings before interest & taxes is $214.19M
What is Collegium Pharmaceutical, Inc. TTM EBIT year-on-year change?
Over the past year, COLL TTM earnings before interest & taxes has changed by -$78.89M (-36.83%)